Alberts,David S

Institution: M.D. Anderson Cancer Center, USA

Top Collaborators: Roe DJ, Markman M, Tiersten AD, Smith HO, Wilczynski SP, Robinson WR, Hsu CH, Clouser MC, Moon J, Zaino RJ, Janicek MF, Yozwiak M, Bartels HG, Chow HH, Wright HM, Cohen JL, Bartels PH, García FA, Chambers SK, Trimble CL

Research Interests: Cancer, Ovarian Cancer, Risk, Treatment, Platinum, Patients, Recurrence, Metabolism, Skin, Skin Cancer, Chemotherapy, Colonoscopy, Polyp, Regression, Cell, Inhibition, Tumor, Women, Lead, Carcinoma

Publications
Grants

Information and abstracts for author publications
Published Date	Impact	Publication
11/02/2010	7.7	Clinical cancer research : an official journal of the American Association for Cancer Research Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer.	Abstract
03/15/2012	7.7	Clinical cancer research : an official journal of the American Association for Cancer Research Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancer.	Abstract
12/01/2009	4.9	Cancer prevention research (Philadelphia, Pa.) Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients.	Abstract
03/31/2009	4.9	Cancer prevention research (Philadelphia, Pa.) Chemoprevention of human actinic keratoses by topical DL-alpha-tocopherol.	Abstract
12/10/2012	4.9	Cancer prevention research (Philadelphia, Pa.) Difluoromethylornithine: the proof is in the polyamines.	Abstract
08/17/2010	4.9	Cancer prevention research (Philadelphia, Pa.) Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study.	Abstract
02/24/2009	4.1	Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology Analysis of colorectal adenoma recurrence data subject to informative censoring.	Abstract
12/09/2011	3.9	Gynecologic oncology Karyometry in atypical endometrial hyperplasia: a Gynecologic Oncology Group study.	Abstract
01/12/2009	3.9	Gynecologic oncology Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009.	Abstract
12/30/2009	3.9	Gynecologic oncology Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: final survival results of a SWOG (S0200) phase 3 randomized trial.	Abstract
11/08/2010	2.8	Nutrition and cancer Dose response of retinol and isotretinoin in the prevention of nonmelanoma skin cancer recurrence.	Abstract
09/29/2009	2.7	BMC medical research methodology Estimation of colorectal adenoma recurrence with dependent censoring.	Abstract
02/02/2010	2.3	Oncology Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: a Southwest Oncology Group Study.	Abstract

Grants Recieved by this author
Budget Start	Budget End	Grant Type	Project Cost	Project Title
9/21/2010	8/31/2014	NIH R25: Education Projects	$2,115,299	Cancer Prevention and Control Translational Research
9/28/2009	8/31/2014	NIH U54: Specialized Center--Cooperative Agreements	$6,800,710	The Partnership for Native American Cancer Prevention (2 of 2)
7/23/2008	6/30/2014	NIH P01: Research Program Projects	$8,636,640	Chemoprevention of Skin Cancer Program Project
8/19/2009	6/30/2014	NIH P30: Center Core Grants	$17,239,558	Arizona Cancer Center-Cancer Center Support Grant
8/19/2009	6/30/2014	NIH P30: Center Core Grants	$1,493,233	Senior Leaders
8/19/2009	6/30/2014	NIH P30: Center Core Grants	$563,346	Planning and Evaluation
8/19/2009	6/30/2014	NIH P30: Center Core Grants	$2,488,961	Development
8/19/2009	6/30/2014	NIH P30: Center Core Grants	$2,271,003	Administration
5/01/2008	8/31/2010	NIH R25: Education Projects	$1,022,104	Cancer Prevention and Control Training Grant
7/01/2008	6/30/2009	NIH P01: Research Program Projects	$1,796,242	Phase I &II studies of topical agents for chemoprevention of skin cancer
7/01/2007	6/30/2009	NIH P30: Center Core Grants	$4,063,721	Arizona Cancer Center Support Grant

Alberts,David S

Related JoVE Videos